| Identification | Back Directory | [Name]
4-methyl-N-(9H-xanthen-9-yl)benzamide | [CAS]
6319-64-8 | [Synonyms]
TUG-1387
TUG-1387 >=98% (HPLC)
4-methyl-N-(9H-xanthen-9-yl)benzamide
Benzamide, 4-methyl-N-9H-xanthen-9-yl- | [Molecular Formula]
C21H17NO2 | [MDL Number]
MFCD00391848 | [MOL File]
6319-64-8.mol | [Molecular Weight]
315.37 |
| Chemical Properties | Back Directory | [storage temp. ]
Store at -20°C | [solubility ]
DMSO: 2mg/mL, clear (warmed) | [form ]
Powder | [color ]
White to off-white | [InChI]
1S/C21H17NO2/c1-14-10-12-15(13-11-14)21(23)22-20-16-6-2-4-8-18(16)24-19-9-5-3-7-17(19)20/h2-13,20H,1H3,(H,22,23) | [InChIKey]
RWLHMQMVSKQATK-UHFFFAOYSA-N | [SMILES]
O=C(C1=CC=C(C)C=C1)NC2C3=C(C=CC=C3)OC4=C2C=CC=C4 |
| Hazard Information | Back Directory | [Uses]
TUG-1387 is a control compound for the FFA4 antagonists AH-7614 (HY-19996) and TUG-1506 without inhibitroy activity against FFA4. TUG-1387 can be used as a negative control for FFA4 functional assessments[1]. | [Biological Activity]
TUG-1387 is a analog of both AH-7614 and TUG-1506 that has no activity at FFA4. TUG-1387 can serve as negative control for studies assessing FFA4 function. | [References]
[1]. Watterson KR, et al. Probe-Dependent Negative Allosteric Modulators of the Long-Chain Free Fatty Acid Receptor FFA4. Mol Pharmacol. 2017 Jun;91(6):630-641.[2]. Milligan G, et al. FFA4/GPR120: Pharmacology and Therapeutic Opportunities. Trends Pharmacol Sci. 2017 Sep;38(9):809-821. |
|
| Company Name: |
Energy Chemical
|
| Telephone: |
021-58432009 400-005-6266 |
| Website: |
http://www.energy-chemical.com |
|